PELI Logo
title

References - Key Nutrients and Herbs for Pain and Inflammation

  1. Calder PC. Omega-3 fatty acids and inflammatory processes: from molecules to man. Biochemical Society Transactions. 2017 Oct 15;45(5):1105-15.
  2. Ballester P, Cerdá B, Arcusa R, Marhuenda J, Yamedjeu K, Zafrilla P. Effect of Ginger on inflammatory diseases. Molecules. 2022 Oct 25;27(21):7223. DOI:10.3390/molecules27217223
  3. Abdulkhaleq LA, Assi MA, Abdullah R, Zamri-Saad M, Taufiq-Yap YH, Hezmee MNM. The crucial roles of inflammatory mediators in inflammation: A review. Vet World. 2018 May;11(5):627-35.
  4. Chávez-Castillo M, Ortega Á, Cudris-Torres L, Duran P, Rojas M, Manzano A, et al. Specialized Pro-Resolving Lipid Mediators: The Future of Chronic Pain Therapy?. IJMS. 2021 Sep 26;22(19):10370. DOI:10.3390/ijms221910370
  5. Fukuishi N, Takahama K, Kurosaki H, Ono S, Asai H. The Role of Endogenous Specialized Proresolving Mediators in Mast Cells and Their Involvement in Inflammation and Resolution. IJMS. 2025 Feb 11;26(4):1491. DOI:10.3390/ijms26041491
  6. Basil MC, Levy BD. Specialized pro-resolving mediators: endogenous regulators of infection and inflammation. Nat Rev Immunol. 2016 Jan;16(1):51-67. DOI: 10.1038/nri.2015.4
  7. Serhan CN, Levy BD. Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators. J Clin Invest. 2018 Jul;128(7):2657-2669. DOI: 10.1172/JCI97943
  8. Tao X, Lee MS, Donnelly CR, Ji RR. Neuromodulation, specialized proresolving mediators, and resolution of pain. Neurotherapeutics. 2020 Jul;17(3):886-899. DOI: 10.1007/s13311-020-00892-9
  9. Fattori V, Zaninelli TH, Rasquel-Oliveira FS, Casagrande R, Verri WA. Specialized pro-resolving lipid mediators: a new class of non-immunosuppressive and non-opioid analgesic drugs. Pharmacol Res. 2020 Jan;151:104549. DOI: 10.1016/j.phrs.2019.104549
  10. Han YH, Lee K, Saha A, Han J, Choi H, Noh M, et al. Specialized proresolving mediators for therapeutic interventions targeting metabolic and inflammatory disorders. Biomol Ther (Seoul). 2021 Sep;29(5):455-464. DOI: 10.4062/biomolther.2021.094
  11. Fredman G, Spite M. Specialized pro-resolving mediators in cardiovascular diseases. Mol Aspects Med. 2017 Dec;58:65-71. DOI: 10.1016/j.mam.2017.02.003
  12. Valente M, Dentoni M, Bellizzi F, Kuris F, Gigli GL. Specialized pro-resolving mediators in neuroinflammation: overview of studies and perspectives of clinical applications. Molecules. 2022 Jul;27(15):4836. DOI: 10.3390/molecules27154836
  13. Zaninelli TH, Fattori V, Verri WA. Harnessing inflammation resolution in arthritis: current understanding of specialized pro-resolving lipid mediators' contribution to arthritis physiopathology and future perspectives. Front Physiol. 2021;12:729134. DOI: 10.3389/fphys.2021.729134
  14. Lavy M, Gauttier V, Poirier N, Barillé-Nion S, Blanquart C. Specialized pro-resolving mediators mitigate cancer-related inflammation: role of tumor-associated macrophages and therapeutic opportunities. Front Immunol. 2021;12:702785. DOI: 10.3389/fimmu.2021.702785
  15. Callan N, Hanes D, Bradley R. Early evidence of efficacy for orally administered SPM-enriched marine lipid fraction on quality of life and pain in a sample of adults with chronic pain. J Transl Med. 2020 Oct;18(1):401. DOI: 10.1186/s12967-020-02569-5
  16. Möller I, Rodas G, Villalón JM, Rodas JA, Angulo F, Martínez N, et al. Randomized, double-blind, placebo-controlled study to evaluate the effect of treatment with an SPMs-enriched oil on chronic pain and inflammation, functionality, and quality of life in patients with symptomatic knee osteoarthritis: GAUDI study. J Transl Med. 2023 Jun;21(1):423. DOI: 10.1186/s12967-023-04283-4
  17. Das P, Dutta A, Panchali T, Khatun A, Kar R, Das TK, et al. Advances in therapeutic applications of fish oil: A review. Measurement: Food. 2024 Mar;13:100142. DOI:10.1016/j.meafoo.2024.100142
  18. Clayton P, Hill M, Bogoda N, Subah S, Venkatesh R. Palmitoylethanolamide: A Natural Compound for Health Management. IJMS. 2021 May 18;22(10):5305. DOI:10.3390/ijms22105305
  19. Lang-Illievich K, Klivinyi C, Lasser C, Brenna CTA, Szilagyi IS, Bornemann-Cimenti H. Palmitoylethanolamide in the Treatment of Chronic Pain: A Systematic Review and Meta-Analysis of Double-Blind Randomized Controlled Trials. Nutrients. 2023 Mar 10;15(6):1350. DOI:10.3390/nu15061350
  20. Artukoglu BB, Beyer C, Zuloff-Shani A, Brener E, Bloch MH. Efficacy of Palmitoylethanolamide for Pain: A Meta-Analysis. Pain Physician. 2017 Jul;20(5):353-62.
  21. Marini I, Bartolucci ML, Bortolotti F, Gatto MR, Bonetti GA. Palmitoylethanolamide versus a nonsteroidal anti-inflammatory drug in the treatment of temporomandibular joint inflammatory pain. J Orofac Pain. 2012;26(2):99-104.
  22. Evangelista M, Cilli V, De Vitis R, Militerno A, Fanfani F. Ultra-micronized Palmitoylethanolamide Effects on Sleep-wake Rhythm and Neuropathic Pain Phenotypes in Patients with Carpal Tunnel Syndrome: An Open-label, Randomized Controlled Study. CNS & Neurol Disord Drug Targets. 2018;17(4):291-298. DOI: 10.2174/1871527317666180420143830
  23. Brotini S, Schievano C, Guidi L. Ultra-micronized Palmitoylethanolamide: An Efficacious Adjuvant Therapy for Parkinson’s Disease. CNSNDDT. 2017 Aug 23;16(6):705-13. DOI:10.2174/1871527316666170321124949
  24. Kocaadam B, Şanlier N. Curcumin, an active component of turmeric (Curcuma longa), and its effects on health. Crit. Rev. Food Sci. Nutr. 2017 Sep 2;57(13):2889-95.
  25. Mazidi M, Karimi E, Meydani M, Ghayour-Mobarhan M, Ferns GA. Potential effects of curcumin on peroxisome proliferator-activated receptor-γ in vitro and in vivo. WJM. 2016;6(1):112. DOI:10.5662/wjm.v6.i1.112
  26. Panknin TM, Howe CL, Hauer M, Bucchireddigari B, Rossi AM, Funk JL. Curcumin supplementation and human disease: a scoping review of clinical trials. IJMS. 2023 Feb 24;24(5):4476. DOI:10.3390/ijms24054476
  27. Dhaneshwar SS. An update on pharmacological profile of Boswellia serrata. Asian J Pharm Clin Res. 2019 May 6;12(5):49-56. DOI:10.22159/ajpcr.2019.v12i5.31260
  28. Biagi M, Sarill M, Collotta D, Di Giacomo S, Di Sotto A, Grilli M, et al. From preclinical to clinical evidence: exploring the multiple perspectives and healing power of Boswellia serrata Roxb. ex Colebr. Pharm Adv. 2023 Sep;05(01):29.
  29. Ballester P, Cerdá B, Arcusa R, Marhuenda J, Yamedjeu K, Zafrilla P. Effect of Ginger on inflammatory diseases. Molecules. 2022 Oct 25;27(21):7223. DOI:10.3390/molecules27217223
  30. Crichton M, Davidson AR, Innerarity C, Marx W, Lohning A, Isenring E, et al. Orally consumed ginger and human health: an umbrella review. The American Journal of Clinical Nutrition. 2022 Jun;115(6):1511-27. DOI:10.1093/ajcn/nqac035
  31. Shara M, Stohs SJ. Efficacy and Safety of White Willow Bark (Salix alba) Extracts. Phytotherapy Research. 2015 Aug;29(8):1112-6. DOI:10.1002/ptr.5377


logo

Your one stop destination for education and clinical tools, driven by our purpose to inspire people to live better lives through natural healthcare.

Customer Care or Clinical Support

1300 654 336

or visit www.myintegria.com

© 2025, Integria is a registered trademark of Integria Healthcare (Australia) Pty Ltd

Terms of Use | Privacy | Policies